BAC
53
3
RL
72
4
SYY
53
4
VMC
57
4
WU
32
2
EL
25
4
EFX
38
2
LEG
36
4
TJX
64
2
CAH
48
-5
ORCL
65
-2
MAT
46
12
MCHP
41
4
MCD
52
2
EQIX
64
2
SLB
55
2
MET
72
5
CMA
61
5
ROST
63
12
CCI
31
3
BAC
53
3
RL
72
4
SYY
53
4
VMC
57
4
WU
32
2
EL
25
4
EFX
38
2
LEG
36
4
TJX
64
2
CAH
48
-5
ORCL
65
-2
MAT
46
12
MCHP
41
4
MCD
52
2
EQIX
64
2
SLB
55
2
MET
72
5
CMA
61
5
ROST
63
12
CCI
31
3
Financhill
Back

Voyager Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34

VYGR
Voyager Therapeutics

Last Price:
5.65
Seasonality Move:
0.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Voyager Therapeutics Price Quote

$5.65
0.00 (4.05%)
(Updated: November 23, 2024 at 6:00 AM ET)

Voyager Therapeutics Key Stats

Sell
34
Voyager Therapeutics (VYGR) is a Sell
Day range:
$5.41 - $5.72
52-week range:
$5.19 - $11.72
Dividend yield:
0%
P/E ratio:
1.90
P/S ratio:
1.93
P/B ratio:
0.94%
Volume:
359.9K
Avg. volume:
649.2K
1-year change:
-17.81%
Market cap:
$308.9M
Revenue:
$250M
EPS:
$0.65

How Much Does Voyager Therapeutics Make?

Is Voyager Therapeutics Growing As A Company?

  • What Is Voyager Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 4.34%
  • What Is Voyager Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Voyager Therapeutics Stock Price Performance

What Is Voyager Therapeutics 52-Week High & Low?

Voyager Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Voyager Therapeutics?

Is Voyager Therapeutics Cash Flow Positive?

  • What Is VYGR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$24.5M
  • What Is Voyager Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $113.9M
  • What Is Voyager Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$40.8M

Voyager Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    VYGR return on invested capital is 9.12%
  • What Is Voyager Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 6.54%
  • What Is VYGR Return On Equity?
    ROE is a measure of profitability and is 9.12%

Voyager Therapeutics Earnings Date & Stock Price

Voyager Therapeutics Competitors

Voyager Therapeutics Dividend Yield

Voyager Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 60.49%
Revenue: 433.79% 110.46%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 17.22
Upside from Last Price: 204.55%

Major Shareholders

  • How many VYGR shares are owned by institutional investors?
    50.1M VYGR shares are owned by institutional investors
  • How many VYGR shares are owned by insiders?
    3M VYGR shares are owned by insiders